Ascendis Pharma A/S Liabilities Arising From Financing Activities
Ascendis Pharma A/S (ASND) had Liabilities Arising From Financing Activities of EUR 871.79 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:LiabilitiesArisingFromFinancingActivities · last filed 2026-02-11
- 2025-12-31: Liabilities Arising From Financing Activities 871.79M EUR.
- 2024-12-31: Liabilities Arising From Financing Activities 856.62M EUR.
- 2023-12-31: Liabilities Arising From Financing Activities 644.26M EUR.
- 2022-12-31: Liabilities Arising From Financing Activities 508.38M EUR.
| Period end | Liabilities Arising From Financing Activities |
|---|---|
| 2025-12-31 | 871.79M EUR 20-F · filed 2026-02-11 |
| 2024-12-31 | 856.62M EUR 20-F · filed 2026-02-11 |
| 2023-12-31 | 644.26M EUR 20-F · filed 2026-02-11 |
| 2022-12-31 | 508.38M EUR 20-F · filed 2025-02-12 |
| 2021-12-31 | 104.96M EUR 20-F · filed 2024-02-07 |
| 2020-12-31 | 91.97M EUR 20-F · filed 2023-02-16 |